Dear Healthcare Provider Letter: Genentech

First Page		Document Content
Sunitinib Genentech Renal cell carcinoma Schistocyte Food and Drug Administration Thrombocytopenia Microangiopathic hemolytic anemia Medicine Pharmacology Bevacizumab		Dear Healthcare Provider Letter: Genentech Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 46,22 KB Share Document on Facebook

	Catheter-Directed Thrombolysis with Direct Intra-Catheter Administration of Argatroban and Alteplase for Extensive Deep Vein Thrombosis in a Patient with Heparin-Induced Thrombocytopenia DocID: 1vmHH - View Document
	Guidance on Platelet Transfusion for Patients With Hypoproliferative Thrombocytopenia COG Supportive Care Endorsed Guidelines Click here to see all the COG Supportive Care Endorsed Guidelines. DISCLAIMER DocID: 1uSsq - View Document
	ORIGINAL ARTICLE Gram-negative bacteria are more inclined to cause thrombocytopenia than Gram-positive ones in the bloodstream infections Chao Lin1#, PhD, Xingxing Zhou1#, PhD, Furong Ying1#, PhD, Dongwei Hu1, PhD, Qing DocID: 1u55t - View Document
	Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material to provide convenience for users. In the event of inconsistency between the Japanese original and this English transl DocID: 1qEY9 - View Document
	· THROMBOCY TOPENIA · Complement Blockade with C1 Esterase Inhibitor in Refractory Immune Thrombocytopenia Erin Roesch, MD, and Catherine Broome, MD DocID: 1q1KX - View Document